Immedica Pharma US, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$1.0Mgeneral payments (2019-2025)
$23Kresearch payments (2019-2025)
1,234clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Sarah Noonberg | Castro Valley, CA | Internal Medicine | $368,578.43 |
| Michael Rogawski | Sacramento, CA | Neurology (Psychiatry & Neurology) | $70,889.66 |
| Rajsekar Rajaraman | Los Angeles, CA | Neurology With Special Qualifications In Child Neurology | $48,776.02 |
| Jesus Pina Garza | Nashville, TN | Neurology With Special Qualifications In Child Neurology | $42,421.32 |
| Alison Dolce | Irving, TX | Neurology With Special Qualifications In Child Neurology | $20,701.87 |
| Michael Perry | Fort Worth, TX | Neurology With Special Qualifications In Child Neurology | $20,596.68 |
| Mary Kay Koenig | Houston, TX | Neurology With Special Qualifications In Child Neurology | $20,190.01 |
| Steven Wolf | New York, NY | Neurology (Psychiatry & Neurology) | $20,055.49 |
| Santiago Arroyo | Charlestown, MA | Neurology (Psychiatry & Neurology) | $19,386.27 |
| James Wheless | Memphis, TN | Neurology With Special Qualifications In Child Neurology | $18,571.04 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.